Antiviral drug resistance occurs when viruses undergo genetic mutations that reduce or eliminate the effectiveness of antiviral medications. High mutation rates in viruses such as HIV, influenza, and hepatitis viruses, along with inappropriate or incomplete treatment, contribute to the emergence of resistant strains. Understanding the mechanisms of resistance is essential for developing next-generation antivirals, combination therapies, and effective treatment strategies to combat evolving viral infections.
Market Analysis:
The global antiviral drugs market continues to grow, driven by the increasing burden of viral diseases, rising investment in antiviral research, and the demand for innovative therapies. As of 2026, the market is estimated at approximately USD 69 billion and is projected to reach over USD 98 billion by 2032, growing at a CAGR of around 6%. Growth is supported by advancements in antiviral drug development, combination therapies, and expanding healthcare access, with North America leading the market while the Asia-Pacific region is expected to witness the fastest growth.
ALSO READ Infectious Diseases and Global Health Viral Infections Bacterial Infections Fungal Infections Vector-borne Diseases Virology and HIVAIDS Immunology and Clinical Microbiology Antiviral Drug Resistance Catheter-Associated Urinary Tract Infection Emerging Infectious Diseases Hospital-Acquired Infections HAIs Maternal-Fetal Infections Next-Generation Antibiotics Pediatric Infectious Diseases Sepsis Diagnosis and Care Zoonotic Diseases Neurological and CNS Infections Healthcare-Associated Infections Ophthalmological Infectious Diseases Lower Respiratory and Pediatric IDs Genomics and Infectious disease Special Session on COVID-19 Vaccines and Immunizations Antibiotic Sensitivity Testing Blood-Borne Disease Contagious Disease Encephalitis Global Pandemic Preparedness Influenza Surveillance Systems Microbiome and Immunity Occupational Safety and Health OSH Point-of-Care Testing POCT Travel-Related Infections Tropical Diseases and Parasitic Diseases Sexually Transmitted Diseases and STIs Pathophysiology and Diagnosis Clinical Trials and Case Studies Influencing Factors of IDs Advanced Treatments and Technologies Oral and Maxillofacial Infections Prevention and Control Public Health and Epidemiology Artificial Intelligence in ID Climate Change and Infections Gastroenteritis HIV and Co-Infections Malaria Elimination Strategies Neglected Tropical Diseases NTDs One Health Approach Rapid Diagnostic Innovations Tuberculosis Drug Resistance
Tags
Contagious Diseases Conferences
Infection Conferences 2027 Asia
Public Health Conferences
Infection Conferences 2027
Infectious Diseases Conferences Europe
Infection Conferences 2026 Europe
Microbiology Conferences
Epidemiology Conferences
Bacteriology Conferences
HIV/AIDS Conferences
Infection Conferences 2026
Mycology Conferences
Entomology Conferences
Parasitology Conferences
Infection Conferences 2026 USA